Study to evaluate the effect of Tangshen Fang combined with guideline‐directed medical treatment on the quality of life and clinical outcomes in patients with diabetic nephropathy: A clinical trial on constructing a novel paradigm of integrated traditional Chinese and Western medicine in the treatment of diabetic nephropathy
Advanced Chinese Medicine · 2024
DOI: 10.1002/acm4.19 ↗Abstract
Abstract Background Diabetic kidney disease (DKD) is one of the most common microvascular complications of diabetes mellitus and has become the primary cause of end‐stage renal disease in China. In patients with severe renal insufficiency, Western medical treatments often yield unsatisfactory results. Preliminary studies have indicated that the Chinese herbal formula Tangshen Fang improves estimated glomerular filtration rate (eGFR) in patients with DKD. Methods/design This is a multicenter, randomized, open‐label, controlled clinical trial. DKD patients with eGFR levels between 25 and 75 mL/min (1.73 m 2 ) and urinary albumin‐to‐creatinine ratio (UACR) ≥ 30 mg/g, or eGFR level between 25 and 60 mL/min (1.73 m 2 ) and UACR
EUVIMED